This is promising for humans, too
Clinical trials in patients with metabolic syndrome reveal that L-Carnitine supplementation of 2 g/day for extended periods (25-50 weeks) significantly reduces fasting blood glucose, HbA1c, homeostatic model assessment-insulin resistance (HOMA-IR), inflammatory markers including C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-), and triglyceride levels
2 Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran
Employers need the right foundation to set their plan up for success: the right strategy, right pharmacy benefits manager (PBM), and right care support partner
Burns recommended
LifeMD is focusing on partnerships with leading pharmaceutical manufacturers as part of its growth strategy and aims to provide accessible, high-quality obesity and metabolic care